Invitrogen releases first microarray with yeast proteome
Invitrogen Corporation is to launch the Yeast ProtoArray, the first commercial release of a comprehensive protein microarray, or protein chip, for general research applications.
Invitrogen Corporation is to launch the Yeast ProtoArray, the first commercial release of a comprehensive protein microarray, or protein chip, for general research applications.
This high-throughput technology permits simultaneous and rapid screening of thousands of proteins in a miniaturised format that is compatible with standard laboratory equipment. The release of the Yeast ProtoArray is an important step toward applying this powerful microarray technology to protein studies in humans, and as a result Invitrogen also intends to release microarray chips containing collections of human proteins beginning in the fall of 2004.
'Studying large groups of proteins with this detail and at this speed has not been possible until now,' said Gregory Lucier, Invitrogen's president and CEO. 'These revolutionary protein microarrays, which have the potential to streamline drug target identification, selection and validation, are of particular relevance to our pharmaceutical and biotechnology partners who are seeking more efficient and effective drug discovery technologies.'